Coastal Infusion Administers Nulojix®
| J-Code | J0485 |
|---|---|
| Manufacturer | Bristol-Myers Squibb |
| First Approved | 06/15/2011 |
Coastal Infusion can administer your Nulojix prescription at any of our south Florida locations.
Nulojix (belatacept) is used to prevent organ rejection after a kidney transplant.
The active substance in Nulojix, belatacept, is an immunosuppressive medicine. Nulojix works by blocking a specific immune system cell, known as a T-cell, from attacking the transplanted kidney, helping to prevent organ rejection.
An interleukin-2-receptor-antagonist medicine should also be used with Nulojix during the first week after the kidney transplant.
What It Treats
Nulojix is used to treat organ rejection from a kidney transplant.
Prescribed By
Nulojix is most often prescribed by Nephrologists, Immunologists, and transplant surgeons.
How it’s Administered
Nulojix is administered by intravenous infusion. Nulojix infusions take about 30 minutes.
Frequency
Nulojix is generally administered on the day of the transplant, then at Day 5, Week 2, Week 4 and every 4 weeks thereafter.
Additional Resources
The information on this page is compiled from a variety of online sources. Coastal Infusion has made every effort to verify its accuracy, but patients are advised to discuss any planned or current treatments with their doctor. Report inaccuracies